Single treatment with Nutlin-3 is less efficient in inhibiting the growth or promoting apoptosis of some cancer cells, such as HCT116+/+, H460, or A549, in xenograft tumor models even though these cells contain wild type p53. This evidence concerns the gene TP53 and cancer.